4//SEC Filing
McElhaugh Michael J. 4
Accession 0001447028-25-000038
CIK 0001447028other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:02 PM ET
Size
325.0 KB
Accession
0001447028-25-000038
Insider Transaction Report
Form 4
McElhaugh Michael J.
DirectorInterim President & CEO
Transactions
- Sale
Common Shares
2025-02-04$3.28/sh−23,790$78,103→ 1,481,003 total
Footnotes (1)
- [F1]Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 3, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units.
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeother
Related Parties
1- filerCIK 0001635326
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:02 PM ET
- Size
- 325.0 KB